XHS vs. IBB
Compare and contrast key facts about SPDR S&P Health Care Services ETF (XHS) and iShares Nasdaq Biotechnology ETF (IBB).
XHS and IBB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XHS is a passively managed fund by State Street that tracks the performance of the S&P Health Care Services Select Industry Index. It was launched on Sep 28, 2011. IBB is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology Index. It was launched on Feb 5, 2001. Both XHS and IBB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XHS or IBB.
Key characteristics
| XHS | IBB | |
|---|---|---|
| YTD Return | -0.39% | -2.04% |
| 1Y Return | 3.23% | 2.36% |
| 3Y Return (Ann) | -7.06% | -3.74% |
| 5Y Return (Ann) | 7.16% | 4.55% |
| 10Y Return (Ann) | 7.33% | 5.93% |
| Sharpe Ratio | 0.12 | 0.12 |
| Daily Std Dev | 16.83% | 16.73% |
| Max Drawdown | -39.32% | -62.85% |
| Current Drawdown | -22.96% | -23.94% |
Correlation
The correlation between XHS and IBB is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
XHS vs. IBB - Performance Comparison
In the year-to-date period, XHS achieves a -0.39% return, which is significantly higher than IBB's -2.04% return. Over the past 10 years, XHS has outperformed IBB with an annualized return of 7.33%, while IBB has yielded a comparatively lower 5.93% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XHS vs. IBB - Expense Ratio Comparison
XHS has a 0.35% expense ratio, which is lower than IBB's 0.47% expense ratio.
Risk-Adjusted Performance
XHS vs. IBB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Services ETF (XHS) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XHS vs. IBB - Dividend Comparison
XHS's dividend yield for the trailing twelve months is around 0.26%, less than IBB's 0.31% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XHS SPDR S&P Health Care Services ETF | 0.26% | 0.23% | 0.19% | 0.20% | 0.23% | 2.37% | 0.34% | 0.22% | 0.28% | 0.93% | 1.17% | 0.46% |
IBB iShares Nasdaq Biotechnology ETF | 0.31% | 0.26% | 0.31% | 0.21% | 0.21% | 0.17% | 0.20% | 0.30% | 0.19% | 0.03% | 0.15% | 0.03% |
Drawdowns
XHS vs. IBB - Drawdown Comparison
The maximum XHS drawdown since its inception was -39.32%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for XHS and IBB. For additional features, visit the drawdowns tool.
Volatility
XHS vs. IBB - Volatility Comparison
The current volatility for SPDR S&P Health Care Services ETF (XHS) is 3.96%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 5.77%. This indicates that XHS experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.